JAMA Network
About The Study: The findings of this study suggest that plasma biomarkers' distinct trajectories and clinical associations in early-onset Alzheimer disease and frontotemporal dementia support their potential utility for risk stratification.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
